(Q26744257)

BioMed Research International

26 August 2020

anti-inflammatory agent

1 reference

19 July 2021

Jan Krejci

1

0 references

Dalibor Mlejnek

series ordinal

2

0 references

Dana Sochorova

series ordinal

3

0 references

Petr Nemec

series ordinal

4

0 references

language of work or name

English

0 references

publication date

12 June 2016

5 references

22 March 2019

17 June 2019

25 June 2019

26 August 2020

19 July 2021

6 references

22 March 2019

17 June 2019

25 June 2019

26 August 2020

19 July 2021

2016

0 references

page(s)

4087632

0 references

copyright license

Creative Commons Attribution 4.0 International

5 references

22 March 2019

17 June 2019

25 June 2019

26 August 2020

on focus list of Wikimedia project

19 July 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

7 April 2017

Update on myocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

7 April 2017

Acute viral myocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Current therapeutic concepts in peripartum cardiomyopathy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

New therapeutic aspects of inflammatory cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Immunosuppressive therapy in myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

MiR-155 and miR-148a reduce cardiac injury by inhibiting NF-κB pathway during acute viral myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Immunosuppressive treatment for myocarditis: a meta-analysis of randomized controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Molecular phenotypes of human parvovirus B19 in patients with myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Diagnostic use of the endomyocardial biopsy: a consensus statement

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Sex and gender differences in myocarditis and dilated cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Idiopathic giant cell myocarditis and cardiac sarcoidosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Viral myocarditis: from experimental models to molecular diagnosis in patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Current status of endomyocardial biopsy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

The management of myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Transcriptomic biomarkers for the accurate diagnosis of myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

African-American women have a higher risk for developing peripartum cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Genomic and proteomic analysis of myocarditis and dilated cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Myocarditis: infection versus autoimmunity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Detection of antibodies in cardiac autoimmunity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Usefulness of immunosuppression for giant cell myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Antiviral treatment of myocarditis and acute dilated cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Improved outcomes in peripartum cardiomyopathy with contemporary

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Diagnosis of myocarditis: death of Dallas criteria

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Detection of Borrelia burgdorferi sensu lato in endomyocardial biopsy specimens in individuals with recent-onset dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Parvovirus B19 is a bystander in adult myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

High prevalence of viral genomes and inflammation in peripartum cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Virus serology in patients with suspected myocarditis: utility or futility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

miRNA as activity markers in Parvo B19 associated heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Analysis of endomyocardial biopsies in suspected myocarditis--diagnostic value of left versus right ventricular biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Anti-inflammatory effects of eplerenone on viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Clinical significance of corticosteroid therapy for eosinophilic myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4921131

Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load

28 November 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F4087632

Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression

21 January 2018

1 reference

12 December 2020

Cardiac troponin T in patients with clinically suspected myocarditis

1 reference

12 December 2020

Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet

1 reference

12 December 2020

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

12 December 2020

Clinical presentation and diagnosis of myocarditis

1 reference

12 December 2020

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

12 December 2020

Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance

1 reference

12 December 2020

The variable clinical course of peripartum cardiomyopathy

1 reference

12 December 2020

Myocarditis. A histopathologic definition and classification

1 reference

12 December 2020

Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error

1 reference

12 December 2020

Peripartum myocarditis and cardiomyopathy

1 reference

12 December 2020

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology

1 reference

12 December 2020

Interferon-Beta improves survival in enterovirus-associated cardiomyopathy

1 reference

12 December 2020

Human parvovirus B19-associated myocarditis

1 reference

12 December 2020

Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery

1 reference

12 December 2020

Diagnosis and management of peripartum cardiomyopathy

1 reference

12 December 2020

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study

1 reference

12 December 2020

Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease

1 reference

12 December 2020

Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study

1 reference

12 December 2020